The US government has taken delivery of the first drug said to cure smallpox. It was developed under a government plan to buy biodefence drugs that would otherwise stall in development for lack of a market. The country plans to buy enough to treat two million people, for $410 million.
On the face of it, that looks like a good plan. Yet as New Scientist reported this week, thousands of people are dying from antibiotic-resistant bacteria, for want of just such funding for new antibiotics. No one has died of smallpox since the disease was declared eradicated in 1980. So what's going on?
Click "source" for more.